Crossmark

Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab

Crossref DOI link: https://doi.org/10.1007/s11060-018-03075-x

Published Online: 2018-12-10

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toh, Cheng Hong https://orcid.org/0000-0002-8871-5101
Liau, Chi-Ting

Wei, Kuo-Chen

Castillo, Mauricio
Funding

Funding for this research was provided by:

National Science Council (MOST 103-2314-B-182-008-MY2, MOST 106-2314-B-182A-017-MY2)
License Information

Text and Data Mining valid from 2018-12-10
More Information

Article History

Received: 9 October 2018

Accepted: 6 December 2018

First Online: 10 December 2018

Compliance with ethical standards

:

: All authors declare that they have no conflict of interest

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants in the study

Document is current

Any future updates will be listed below